NCT00355810

Probiotics for Irritable Bowel Syndrome

Lactobacillus Plantarum MF 1298 vs Placebo for Irritable Bowel Syndrome.

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 19 (actual)
• Sponsor: Norwegian University of Science and Technology · Academic / Other
• Sex: All
• Age: 18 Years – 75 Years
• Healthy volunteers: Not accepted

Summary

This randomised, double blind, cross-over study compares the effect (symptoms, fecal bacterial growth, gas production) of three weeks' treatment with lactobacillus plantarum MF 1298 with placebo in patients with irritable bowel syndrome. The results are related to dietary habits, food intolerance and food allergy.

Conditions

• Functional Gastrointestinal Disorders
• Irritable Bowel Syndrome

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	placebo followed by Lactobacillus plantarum MF 1298	placebo during 3 weeks, washout period 4 weeks, Lactobacillus plantarum MF1298 during 3 weeks
DIETARY_SUPPLEMENT	Lactobacillus plantarum MF1298 followed by placebo	Lactobacillus plantarum MF1298 during 3 weeks, washout period 4 weeks, placebo during 3 weeks

Timeline

• Start date: 2006-01-01
• Primary completion: 2006-04-01
• Completion: 2006-12-01
• First posted: 2006-07-25
• Last updated: 2016-07-19

Locations

1 site across 1 country: Norway